TP53 and diffuse large B-cell lymphoma: Other pathways such as “DNA damage response,” “p53 signaling” and “platelet activation, signalling and aggregation” were also enriched which may provide new insights in the contribution of M-MDSC in the immunosuppression of DLBCL (Figure 6).